The largest database of trusted experimental protocols

Allstars control sirna

Manufactured by Qiagen
Sourced in Germany

Allstars control siRNA is a laboratory reagent used for RNA interference (RNAi) experiments. It is a non-targeting control siRNA that does not recognize any known gene sequences. Allstars control siRNA can be used to determine the effects of the transfection process and off-target effects in RNAi studies.

Automatically generated - may contain errors

6 protocols using allstars control sirna

1

Knockdown of ARF6, MYD88, and ARNO in Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs were diluted in 12.5% by volume HiPerFect Transfection Reagent (Qiagen) in Opti-MEM (Invitrogen) and incubated for at least 10m at room temperature. Passage 3-4 endothelial cells were trypsinized and resuspended in growth media, then combined with siRNAs such that the final concentration of siRNA was 30nM for all targets. Cells were then plated and media was changed the following morning. Three days after the initial transfection, the cells were transfected a second time using HiPerFect/siRNA concentrations as described above. All siRNA treatments were compared to the All-Stars Control siRNA (Qiagen).
 Gene Catalog Number Target sequence (5’-3’) ARF6 SI02757286 CAACGTGGAGACGGTGACTTA MYD88 SI00300909 AACTGGAACAGACAAACTATC ARNO SI00061299 CACGCTGTTGGTAATCTTATT
+ Open protocol
+ Expand
2

siRNA Transfection Protocols for Gene Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs used in this study were purchased from Eurofins MWG Operon and directed against the following target sequences (sense strand): si-TIAR (S62; Mazan-Mamczarz et al., 2006 (link)), 5′-GGG​CUA​UUC​AUU​UGU​CAG​A-3′; si-TIAR (S70; Izquierdo et al., 2011 (link)), 5′-GUC​CUU​AUA​CUU​CAG​UUG​U-3′; si-TIA1 (S63; López de Silanes et al., 2005 (link)), 5′-CGA​UUU​GGG​AGG​UAG​UGA​A-3′; si-TIA1/R (S71; Damgaard and Lykke-Andersen, 2011 (link)), 5′-UUC​CAG​AGA​UGU​GAC​AGA​A-3′. In addition, si-control (S75) represents the AllStars control siRNA (Qiagen). All siRNAs were transfected at a final concentration of 50 nM using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

Silencing GLUT3 and PKM2 in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA was used to silence expression of GLUT3 and PKM2 in Hues-7 hESCs cultured at 5% oxygen on Matrigel-coated plates. hESCs were transfected on the first day after passaging, before a standard medium change 24 hours later. Experiments were performed, or protein was collected, 48 hours after transfection. To silence GLUT3 expression, 50 nM of a previously validated siRNA (Ambion) was used with the transfection reagent INTERFERin (Polyplus). To silence PKM2 expression, 100 nM of a previously described PKM2 specific siRNA (Sense strand: 5′ CCAUAAUCGUCCUCACCAAUU 3′; Thermo Scientific)32 (link) was required, with the transfection reagent HiPerFect (Qiagen). Allstars control siRNA (Qiagen) was transfected into hESCs alongside GLUT3 siRNA and PKM2 siRNA experiments as a negative control.
+ Open protocol
+ Expand
4

Epstein-Barr Virus Reactivation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
AGS-EBV cells were plated in a 6-well dish at 20% confluency and transfected with either 40 pmoles of siSUMO1 (Santa Cruz) or Allstars control siRNA (Qiagen) using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions. The transfection was repeated after 24 and 48 hours. 24 hours later, cells were lysed in 9M urea buffer for Western blot analysis or fixed and stained with anti-BZLF1 for fluorescence microscopy analysis. Lysates were sonicated and clarified by centrifugation. 80 μg of clarified lysate were analyzed by Western blotting with SUMO1, BZLF1 and actin antibodies. The percentage of reactivated cells was determined by performing immunofluorescence microscopy for BZLF1 (as described below), and counting ~300 cells for each sample in three independent experiments.
+ Open protocol
+ Expand
5

Knockdown of CTBP and HIF-2α in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
hESCs maintained on Matrigel at 5% oxygen were passaged and incubated overnight. For each transfection, 50 nM siRNA (CTBP1/2 [Ambion]; CTBP1 [Ambion]; CTBP2 [Ambion]; HIF-2α [QIAGEN]), along with 12 μL INTERFERin for CTBP siRNAs (Polyplus) or HiPerFect for HIF-2α siRNA (QIAGEN) transfection reagent were mixed in 200 μL of KnockOut DMEM (Invitrogen) and added in a drop-wise manner to 1 well of a 6-well plate. Cells were harvested 48 h post-transfection and RNA or protein extracted. Allstars control siRNA (QIAGEN) that has no homology to any known mammalian gene was used as a negative control for each transfection.
For double knockdowns (CTBP1+2 siRNA), 50 nM of each siRNA and 12 μL InterferIN transfection reagent were added to 200 μL of KnockOut DMEM. Twice the volume of Allstars negative control siRNA was added to the controls.
+ Open protocol
+ Expand
6

Cell Imaging with EGFR Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
DLD1, SW480 and HT29 cells were seeded at 2x104 cells/cm2, cultivated on 4 well-chamber slides (Sigma C7057, Taufkirchen, Germany) over-night and treated with anti-EGFR monoclonal antibody cetuximab-protamine or cetuximab alone incubated with Alexa Fluor 488-labeled Allstars control siRNA (Qiagen 1027284, Hilden, Germany) and Allstars negative control siRNA-Alexa 555 (Qiagen 1027286, Hilden, Germany) at 1:10 molar ratio each over night at 37 °C and 5% CO2. Subsequently, cells were washed with phosphate buffered saline (PBS), fixed with ice-cold paraformaldehyde (PFA) 4%, stained with Hoechst, mounted with Dako fluorescent mounting medium and photographed on a Zeiss Axioskop.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!